Synbiotic for Reducing Blood Glucose

This invention is a synbiotic nutritional formulation designed to support healthy blood glucose management and improve the health of individuals with type 2 diabetes. In contrast to traditional methods of diabetes management that mainly concentrate on regulating blood sugar levels, this technology aims to enhance the fundamental connection between the gut microbiome and metabolic health through a combination of different microbiome supporting ingredients that help restore gastrointestinal systems and blood glucose management. 

Background: 
Type 2 Diabetes represents an escalating global crisis that impacts millions of individuals and is linked to complications to cardiovascular disease, kidney disease, nerve damage, vision loss, and diminishing quality of life. Current management emphasizes lifestyle changes, glucose-lowering medications, and insulin therapy. While these methods are somewhat effective in regulating blood sugar levels, it leaves patients struggling with long-term metabolic control. In recent scientific reports it’s been shown that people with type 2 diabetes frequently display notable changes in their gut microbiome, including reductions of beneficial bacteria and a decline in the productions of health promoting microbial metabolites. This nutritional formula was created to rectify these fundamental microbiome imbalances through a targeted synbiotic strategy. 

Applications: 

  • Functional foods and beverages
  • Synbiotic nutrition products
  • Gut microbiome health and modulation
  • Prediabetes and blood glucose management
  • Preventive healthcare and chronic disease management
  • Type 2 diabetes management and support


Advantages: 

  • Supports healthy blood glucose management 
  • Addresses underlying metabolic dysfunction
  • Combines multiple microbiome-supporting approaches 
  • Designed to complement existing lifestyle and pharmacological treatments
  • Non-pharmaceutical, food-based intervention 
Patent Information: